Research output per year
Research output per year
- 21 results
Search results
-
2000
To treat, or not to treat: The therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes
Frohman, E., Racke, M. & Van Den Noort, S., 2000, In: Archives of neurology. 57, 7, p. 930-932 3 p.Research output: Contribution to journal › Editorial › peer-review
20 Scopus citations -
2001
Multiple sclerosis and magnetic resonance imaging: Advancement in linking the pictures with the progression
Racke, M. K., Hawker, K. & Frohman, E., Jan 27 2001, In: Archives of neurology. 58, 1, p. 35-36 2 p.Research output: Contribution to journal › Editorial › peer-review
4 Scopus citations -
2004
Fatigue in Multiple Sclerosis: Is the Picture Getting Simpler or More Complex?
Racke, M. K., Hawker, K. & Frohman, E., Feb 2004, In: Archives of neurology. 61, 2, p. 176-177 2 p.Research output: Contribution to journal › Editorial › peer-review
14 Scopus citations -
2007
DNA plasmid vaccination for multiple sclerosis
Stuve, O., Eagar, T. N., Frohman, E. & Cravens, P. D., Oct 2007, In: Archives of neurology. 64, 10, p. 1385-1386 2 p.Research output: Contribution to journal › Editorial › peer-review
5 Scopus citations -
What you see is what you get: Coupling function with structure in the visual system
Frohman, E. & Zivadinov, R., Dec 2007, In: Neurology. 69, 23, p. 2119-2120 2 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
2008
Natalizumab: Benefit outweighs risk in selected patients with multiple sclerosis
Phillips, J. T. & Frohman, E., Nov 2008, In: Therapeutic Advances in Neurological Disorders. 1, 3, p. 151-153 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access1 Scopus citations -
2013
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
Okuda, D. T. & Vrenken, H., Jun 4 2013, In: Neurology. 80, 23, p. 2084-2085 2 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations -
2016
Antinuclear antibodies in neuromyelitis optica: Guardians of the brain?
Monson, N., Feb 1 2016, In: European Journal of Neurology. 23, 2, p. 223-224 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access3 Scopus citations -
Vitamin D during pregnancy and multiple sclerosis: An evolving association
Greenberg, B. M., May 2016, In: JAMA neurology. 73, 5, p. 498-499 2 p.Research output: Contribution to journal › Editorial › peer-review
8 Scopus citations -
2017
Are miRNAs appropriate biomarkers for radiologic measures of tissue injury in multiple sclerosis?
Okuda, D. T., Mar 1 2017, In: JAMA neurology. 74, 3, p. 260-261 2 p.Research output: Contribution to journal › Editorial › peer-review
1 Scopus citations -
2018
Contemporary Topics in Multiple Sclerosis
Okuda, D. T., Feb 2018, In: Neurologic Clinics. 36, 1, p. xiii-xivResearch output: Contribution to journal › Editorial › peer-review
-
2019
Leveraging technology to identify subclinical deficits in radiologically isolated syndrome
Okuda, D., Jan 2019, In: European Journal of Neurology. 26, 1, p. 3-4 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis
Berger, T. & Stuve, O., Mar 5 2019, In: Neurology. 92, 10, p. 451-452 2 p.Research output: Contribution to journal › Editorial › peer-review
11 Scopus citations -
2020
Emerging evidence for noninvasive vagus nerve stimulation for the treatment of vestibular migraine
Beh, S. C., Oct 2 2020, In: Expert review of neurotherapeutics. 20, 10, p. 991-993 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access4 Scopus citations -
Natalizumab wearing-off effect: The hunt for the elusive pharmacodynamic biomarker
Foley, J. F. & Stuve, O., May 10 2020, In: Neurology: Neuroimmunology and NeuroInflammation. 7, 3, e706.Research output: Contribution to journal › Editorial › peer-review
Open Access1 Scopus citations -
2021
Assessment of Biological Interactions Between Multiple Sclerosis Status and Depression for Mortality
Salter, A., Sep 28 2021, In: Neurology. 97, 13, p. 617-618 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Differing Impact of Disease-Modifying Therapy on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?
Dobson, R. & Salter, A., Aug 31 2021, In: Neurology. 97, 9, p. 407-408 2 p.Research output: Contribution to journal › Editorial › peer-review
-
Guest Editorial
Marrie, R. A. & Salter, A., Nov 2021, In: International Journal of MS Care. 23, 6, p. 4 1 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Guest Editorial
Marrie, R. A. & Salter, A., Nov 2021, In: International Journal of MS Care. 23, 6, p. 4 1 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
2022
Editorial: Understanding the concept of pre-clinical autoimmunity
Olsen, N. J., Okuda, D. T., Holers, V. M. & Karp, D. R., Jul 22 2022, In: Frontiers in immunology. 13, 983310.Research output: Contribution to journal › Editorial › peer-review
Open Access2 Scopus citations -
2024
Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials
Marrie, R. A. & Salter, A., Mar 26 2024, In: Neurology. 102, 6, p. e208099Research output: Contribution to journal › Editorial › peer-review